‘Zemiglo’ license lawsuit meets new phase with Sanofi’s marketing data
At a lawsuit between LG Life Sciences and Sanofi-Aventis over close of the Zemiglo’s license, it seems a new phase is going to be developed as Sanofi turned in data about its marketing activity.
The Civil Affairs Department 17 at the Seoul Central District Court had the 5th defense for the claim...
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.